Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Apogee Biotechnology Corporation”

4 pharma patents match "Apogee Biotechnology Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Apogee Biotechnology Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Apogee Biotechnology Corporation” · 30,257 patents in full index Clear search

  1. US 8685936

    Sphingosine kinase inhibitor prodrugs

    Apogee Biotechnology Corporation · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  2. US 8557800

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  3. US 8063248

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  4. US 7338961

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.